Search - tctmd.com

Displaying 121 - 140 of 193

Sort: Relevancy | Date

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Shelley Wood

May 22, 2020

Presentation SCAI 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presenter: Benjamin E. Peterson

May 21, 2020

Podcast TCTMD Talking Points

FORZA: Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses

May 20, 2020

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

Caitlin E. Cox

May 15, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

News Daily News

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

Todd Neale

April 29, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

News Daily News

CABG Over PCI for Severe HFrEF Patients With Complex CAD: Observational Data

Shelley Wood

April 09, 2020

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Todd Neale

April 03, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Todd Neale

April 02, 2020

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Shelley Wood

March 30, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Conference News ACC 2020

Survival Benefit Shown for Radial Artery Grafting in CABG

L.A. McKeown

March 30, 2020

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

News Conference News ACC 2020

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

L.A. McKeown

March 29, 2020

News Conference News ACC 2020

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

Shelley Wood

March 29, 2020

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

L.A. McKeown

March 28, 2020

Advertisement

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

FORZA: Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

CABG Over PCI for Severe HFrEF Patients With Complex CAD: Observational Data

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Survival Benefit Shown for Radial Artery Grafting in CABG

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content